PreprintCited by 3,183Wnt/β-catenin signaling in development and cancerSignaling Pathways in DiseaseHedgehog Signaling Pathway Studies

The DOI matches its Crossref record; 181 of the 190 references it cites were found in a registry or an index.

Wnt signaling and cancer

Open access

Polakis, Paul·2000·Genes & Development

DOI 10.1101/gad.14.15.1837

Open this paper in CoChat — free account Open PDF

Abstract

The regulation of cell growth and survival can be subverted by a variety of genetic defects that alter transcriptional programs normally responsible for controlling cell number. High throughput analysis of these gene expression patterns should ultimately lead to the identification of minimal expression profiles that will serve as common denominators in assigning a cancer to a given category. In the course of defining the common denominators, though, we should not be too surprised to find that cancers within a single category may nevertheless exhibit seemingly disparate genetic defects. The wnt pathway has already provided an outstanding example of this. We now know of three regulatory genes in this pathway that are mutated in primary human cancers and several others that promote experimental cancers in rodents (Fig. 1). In all of these cases the common denominator is the activation of gene transcription by -catenin. The resulting gene expression profile should provide us with a signature common to those cancers carrying defects in the wnt pathway. In this review, the wnt pathway will be covered from the perspective of cancer, with emphasis placed on molecular defects known to promote neoplastic transformation in humans and in animal models.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.14.15.1837

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Kořínek, V., Barker, N., Clevers, H. C., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 4,000
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J. L., Thliveris, A. T., Samowitz, W. S., Carlson, M. L., Gelbert, L. M., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L. N., Robertson, M. A., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,794
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
Nusse, R., & VARMUS, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,864
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824

Show all 190 references

Research works printed but not linked: 1

10.1210/jc.85.1.286 · DOI

Sorted by citations

Items 301–400 of 1,005

Embryonic Stem Cell Markers
Zhao, W., Ji, X., Zhang, F., Li, L., & Ma, L. (2012) · Molecules · doi:10.3390/molecules17066196 · Cited by 235
“Fzd has a large extracellular N-terminal region containing a cysteine-rich domain (CRD), which is involved in the binding to Wnt proteins [36,40].”
Background
Casein kinase I phosphorylates and destabilizes the β-catenin degradation complex
Gao, Z.-H., Seeling, J. M., Hill, V., Yochum, A., & Virshup, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032468199 · Cited by 225
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
Gao, C., Wang, Y., Broaddus, R. R., Sun, L., Xue, F., & Zhang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.23695 · Cited by 227
“Paul Polakis (2000) has summarized CTNNB1 mutation spots and rates in human cancers in detail [93].”
Background
Crystal Structure of a β-Catenin/BCL9/Tcf4 Complex
Sampietro, J., Dahlberg, C. L., Cho, U., Hinds, T. R., Kimelman, D., & Xu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.001 · Cited by 225
Glycosylation and palmitoylation of Wnt‐3a are coupled to produce an active form of Wnt‐3a
Komekado, H., Yamamoto, H., Chiba, T., & Kikuchi, A. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01068.x · Cited by 231
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Voronkov, A. E., & Krauss, S. J. K. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581837 · Cited by 227
WNT Signaling in Disease
Li, N., Kaur, P., Bunnag, N., Suresh, J., Sung, I. C. H., Tan, Q. H., Gruber, J., & Tolwinski, N. S. (2019) · Cells · doi:10.3390/cells8080826 · Cited by 228
“Inappropriate activation of the WNT pathway is also a major factor in human oncogenesis [4].”
Background
The anticancer activity of propolis
Sawicka, D., Car, H., Borawska, M. H., & Nikliński, J. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0004 · Cited by 227
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
Nejak-Bowen, K. N., & Monga, S. P. S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.010 · Cited by 260
Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction
Lévy, L., Yu, W., Labalette, C., Wu, Y., Renard, C.-A., Buendia, M. A., & Neuveut, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3404-3414.2004 · Cited by 220
Hepatitis B virus X protein is essential for the activation of Wnt/β-catenin signaling in hepatoma cells
Cha, M.-Y., Kim, C.-M., Park, Y.-M., & Ryu, W. (2004) · Hepatology · doi:10.1002/hep.20245 · Cited by 223
Wnt/β-Catenin Pathway
Moon, R. T. (2005) · Science s STKE · doi:10.1126/stke.2712005cm1 · Cited by 225
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
Nenkov, M., Ma, Y., Gaßler, N., & Chen, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126262 · Cited by 226
The Invasion Front of Human Colorectal Adenocarcinomas Shows Co-Localization of Nuclear β-Catenin, Cyclin D1, and p16INK4A and Is a Region of Low Proliferation
Jung, A., Schrauder, M., Oswald, U., Knoll, C., Sellberg, P., Palmqvist, R., Niedobitek, G., Brabletz, T., & Kirchner, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63007-6 · Cited by 217
Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Sukhdeo, K., Mani, M., Zhang, Y., Dutta, J., Yasui, H., Rooney, M., Carrasco, D. E., Zheng, M., He, H., Tai, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610299104 · Cited by 219
Expression of all Wnt genes and their secreted antagonists during mouse blastocyst and postimplantation development
Kemp, C. R., Willems, E., Abdo, S., Lambiv, L., & Leyns, L. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20408 · Cited by 219
Epidermal Growth Factor Receptor: A Novel Target of the Wnt/β-Catenin Pathway in Liver
Tan, X., Apte, U. M., Micsenyi, A., Kotsagrelos, E., Luo, J.-H., Ranganathan, S., Monga, D. K., Bell, A. W., Michalopoulos, G. K., & Monga, S. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.013 · Cited by 219
Inhibition of Intestinal Tumorigenesis in Apcmin/+ Mice by (−)-Epigallocatechin-3-Gallate, the Major Catechin in Green Tea
Ju, J., Hong, J., Zhou, J.-N., Pan, Z., Bose, M., Liao, J., Yang, G., Liu, Y. Y., Hou, Z., Lin, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1949 · Cited by 222
RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal Tumorigenesis
Ito, K., Lim, A. C. B., Salto‐Tellez, M., Motoda, L., Osato, M., Chuang, L. S. H., Lee, C. W. L., Voon, D. C., Koo, J. K. W., Wang, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.004 · Cited by 221
Conceptual Evolution of Cell Signaling
Nair, A., Chauhan, P. S., Saha, B., & Kubatzky, K. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133292 · Cited by 238
“Not only the growth factor receptor pathway, but also defects in the Wnt signaling pathway, mainly β-catenin, represent an appropriate drug target in Wnt-signaling associated cancers [189].”
Background
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
Simonetta, K. R., Taygerly, J., Boyle, K., Basham, S. E., Padovani, C., Lou, Y., Cummins, T. J., Yung, S. L., von Soly, S. K., Kayser, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09358-9 · Cited by 217
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Tcf4 can specifically recognize beta-catenin using alternative conformations.
Graham, T. A., Ferkey, D. M., Mao, F., Kimelman, D., & Xu, W. (2001) · Nature Structural Biology · doi:10.1038/nsb718 · Cited by 219
The GSK-3 Inhibitor BIO Promotes Proliferation in Mammalian Cardiomyocytes
Tseng, A.-S. K., Engel, F. B., & Keating, M. T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.08.004 · Cited by 218
Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6
Wu, G., Huang, H., Abreu, J. G., & He, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004926 · Cited by 216
The way Wnt works: Components and mechanism
Saito‐Diaz, K., Chen, T. W., Wang, X., Thorne, C. A., Wallace, H. A., Page, A. W., & Lee, E. N. (2012) · Growth Factors · doi:10.3109/08977194.2012.752737 · Cited by 223
“In addition, to these point mutations, N-terminal in-frame deletions of b-catenin (which remove the GSK3 and CK1a phosphorylation sites) have also been described in cancers (Peifer and Polakis 2000; Laurent-Puig et al. 2001).”
BackgroundInfluential
Micro RNA ‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β ‐catenin pathway
Xu, J., Zhu, X., Wu, L., Yang, R., Yang, Z., Wang, Q., & Wu, F. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02750.x · Cited by 215
Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon Cancer
Shao, J., Jung, C., Liu, C., & Sheng, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413056200 · Cited by 216
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
Vona, G., Estepa, L., Béroud, C., Damotte, D., Capron, F., Nalpas, B., Mineur, A., Franco, D., Lacour, B., Pol, S., et al. (2004) · Hepatology · doi:10.1002/hep.20091 · Cited by 215
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation
Tarte, K., Zhan, F., Vos, J. D., Klein, B., & Shaughnessy, J. D. (2003) · Blood · doi:10.1182/blood-2002-10-3161 · Cited by 215
The Metastasis-Associated Gene S100A4 Is a Novel Target of β-catenin/T-cell Factor Signaling in Colon Cancer
Stein, U., Arlt, F., Walther, W., Smith, J. L., Waldman, T. A., Harris, E. D., Mertins, S. D., Heizmann, C. W., Allard, D., Birchmeier, W., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.041 · Cited by 214
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Huang, J. Y., Nguyen-McCarty, M., Hexner, E. O., Danet-Desnoyers, G. A., & Klein, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2984 · Cited by 221
Crystal Structure of a Full-Length β-Catenin
Xing, Y., Takemaru, K., Liu, J., Berndt, J. D., Zheng, J., Moon, R. T., & Xu, W. (2008) · Structure · doi:10.1016/j.str.2007.12.021 · Cited by 233
Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Rhee, K., Lee, J. E., & Eom, Y. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226215 · Cited by 221
“The WNT signaling pathway has also been associated with the development of carcinomas of the breast, liver, colon, skin, stomach, and ovary [160–171].”
Background
Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo
Murdoch, B., Chadwick, K., Martin, M. A., Shojaei, F., Shah, K. V., Gallacher, L. M., Moon, R. T., & Bhatia, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0130233100 · Cited by 214
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesisPreprint
Gunther, E. J., Moody, S. E., Belka, G. K., Hahn, K. T., Innocent, N., Dugan, K. D., Cardiff, R. D., & Chodosh, L. A. (2003) · Genes & Development · doi:10.1101/gad.1051603 · Cited by 214
Identification of a Specific Inhibitor of the Dishevelled PDZ Domain
Shan, J., Shi, D., Wang, J., & Zheng, J. (2005) · Biochemistry · doi:10.1021/bi0512602 · Cited by 211
DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a –Dependent Mechanism
Sureban, S. M., May, R. J., Lightfoot, S. A., Hoskins, A. B., Lerner, M. R., Brackett, D. J., Postier, R. G., Ramanujam, R. P., Mohammed, A., Rao, C. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2738 · Cited by 213
Regulation of Wnt signaling by protein-protein interaction and post-translational modifications
Kikuchi, A., Kishida, S., & Yamamoto, H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.1 · Cited by 217
Adenomatous Polyposis Coli (APC) Differentially Regulates β-Catenin Phosphorylation and Ubiquitination in Colon Cancer Cells
Yang, J., Zhang, W., Evans, P. M., Chen, X., He, X., & Liu, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600831200 · Cited by 219
Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target
Yu, W., Yang, L., Li, T., & Zhang, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00989 · Cited by 214
“keep the low level of β-catenin in cytoplasm, as well as cell nucleus (56).”
Background
Multiple mechanisms are involved in 6‐gingerol‐induced cell growth arrest and apoptosis in human colorectal cancer cells
Lee, S., Cekanova, M., & Baek, S. J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20374 · Cited by 212
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis
You, Z., Saims, D., Chen, S., Zhang, Z., Guttridge, D. C., Guan, K., MacDougald, O. A., Brown, A. M. C., Evan, G. I., Kitajewski, J., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201110 · Cited by 211
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability
Sarrió, D., Moreno‐Bueno, G., Hardisson, D., Sánchez‐Estévez, C., Guo, M., Herman, J. G., Gamallo, C., Esteller, M., & Palacios, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11197 · Cited by 211
Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC
Green, R. A., & Kaplan, K. B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200307070 · Cited by 211
Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1Preprint
Tao, W., Pennica, D., Xu, L., Kalejta, R. F., & Levine, A. J. (2001) · Genes & Development · doi:10.1101/gad.894301 · Cited by 210
Pygopus and Legless target Armadillo/β-catenin to the nucleus to enable its transcriptional co-activator function
Townsley, F. M., Cliffe, A., & Bienz, M. (2004) · Nature Cell Biology · doi:10.1038/ncb1141 · Cited by 209
Wnt Signaling Pathway in Mammary Gland Development and Carcinogenesis
Turashvili, G., Bouchal, J., Burkadze, G., & Kolář, Z. (2006) · Pathobiology · doi:10.1159/000098207 · Cited by 210
The WNT signalling pathway and diabetes mellitus
Jin, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1084-y · Cited by 211
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
Jiang, Z., Jiang, X., Chen, S., Lai, Y., Wei, X., Li, B., Lin, S., Wang, S., Wu, Q., Liang, Q., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00690 · Cited by 207
“Previous studies show that MET and CTNNB1 act as oncogenes in HCCs and that CCND1 is the hallmark of cell cycle progression (19, 26, 27).”
Background
Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation
Damalas, A., Kahan, S., Shtutman, M. S., Ben‐Ze'ev, A., & Oren, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 208
New Insights into the Mechanism of Action of Soluble Klotho
Dalton, G. D., Xie, J., An, S.-W., & Huang, C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00323 · Cited by 210
“Wnt signaling is initiated when secreted Wnt ligands activate transmembrane receptors that promote the translocation of β-catenin to the nucleus where it induces the activity of transcription factors such as TCF and LEF (77).”
Background
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Guo, X., Jiang, H., Shi, B., Zhou, M., Zhang, H., Shi, Z., Du, G., Luo, H., Wu, X., Wang, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01118 · Cited by 208
“Among three analyzed tumor-related genes, CTNNB1 and MET act as the oncogenes in HCC, and CCND1 is the hallmarker of cell cycle procession (Polakis, 2000; Zhang et al., 2002; Venepalli and Goff, 2013).”
Background
Notch modulates Wnt signalling by associating with Armadillo/β-catenin and regulating its transcriptional activity
Hayward, P., Brennan, K. R., Sanders, P., Balayo, T., DasGupta, R., Perrimon, N., & Arias, A. M. (2005) · Development · doi:10.1242/dev.01724 · Cited by 204
Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Type 2 Diabetes in Large Cohorts of U.S. Women and Men
Zhang, C., Qi, L., Hunter, D. J., Meigs, J. B., Manson, J. E., van Dam, R. M., & Hu, F. B. (2006) · Diabetes · doi:10.2337/db06-0643 · Cited by 207
Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells
Kim, J., Zhang, X., Rieger‐Christ, K., Summerhayes, I. C., Wazer, D. E., Paulson, K. E., & Yee, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513378200 · Cited by 204
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila
Yanagawa, S.-I., Matsuda, Y., Lee, J.-S., Matsubayashi, H., Sese, S., Kadowaki, T., & Ishimoto, A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1733 · Cited by 202
TCF: Lady Justice Casting the Final Verdict on the Outcome of Wnt Signalling
Brantjes, H., Barker, N., van Es, J. H., & Clevers, H. C. (2002) · Biological Chemistry · doi:10.1515/bc.2002.027 · Cited by 202
The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation
Bax, B. D., Carter, P. S., Lewis, C. J., Guy, A. R., Bridges, A. M., Tanner, R., Pettman, G. R., Mannix, C. J., Culbert, A. A., Brown, M. J. B., et al. (2001) · Structure · doi:10.1016/s0969-2126(01)00679-7 · Cited by 209
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Díaz‐Hernandéz, J. I., Gómez‐Villafuertes, R., León‐Otegui, M., Hontecillas‐Prieto, L., del Puerto, A., Trejo, J. L., Lucas, J. J., Garrido, J. J., Gualix, J., Miras‐Portugal, M. T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.040 · Cited by 203
Epigenetic alterations involved in cancer stem cell reprogramming
Muñoz, P., Iliou, M. S., & Esteller, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.006 · Cited by 205
“Gain-of-function mutations of the CTNNB1 gene (encoding b-catenin) and loss-offunction mutations of APC and AXIN genes were identified as the main mechanisms associated to Wnt signaling dysfunction in cancers (Barker and Clevers, 2006; Lindvall et al., 2007; Polakis, 2000).”
Background
Wnt/?-catenin-pathway as a molecular target for future anti-cancer therapeutics
Dihlmann, S., & Doeberitz, M. V. K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20609 · Cited by 204
Cadherins and the tumour progression: is it all in a switch?
Cavallaro, U., Schaffhauser, B., & Christofori, G. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00759-5 · Cited by 201
The Wnt antagonist Dickkopf‐1 is regulated by Bmp signaling and c‐Jun and modulates programmed cell death
Grotewold, L., & Rüther, U. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.966 · Cited by 201
Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways
Pandurangan, A. K. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2201 · Cited by 198
“A deregulation in the Wnt signaling pathway disrupts axis formation in embryos (Heasman et al., 1994; Funayama et al., 1995; Laurent et al., 1997) and is associated with multiple human malignancies (Polakis, 2000).”
Background
Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Chen, J., Zhao, K., & Vitetta, L. (2019) · Nutrients · doi:10.3390/nu11051026 · Cited by 211
Exploration of liver cancer genomes
Shibata, T., & Aburatani, H. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.6 · Cited by 202
Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation
Yun, M.-S., Kim, S., Jeon, S. H., Lee, J., & Choi, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01601 · Cited by 197
Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers
Colnot, S., Niwa‐Kawakita, M., Hamard, G., Godard, C., Plénier, S. L., Houbron, C., Romagnolo, B., Berrebi, D. D., Giovannini, M., & Perret, C. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700180 · Cited by 219
The Wnt connection to tumorigenesis
Behrens, J., & Lustig, B. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041815jb · Cited by 200
Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
Fattet, S., Haberler, C., Legoix, P., Varlet, P., Lellouch‐Tubiana, A., Lair, S., Manié, É., Raquin, M., Bours, D., Carpentier, S., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2514 · Cited by 194
Role of APC and DNA mismatch repair genes in the development of colorectal cancers.
Narayan, S., & Roy, D. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-41 · Cited by 194
TCF Transcription Factors, Mediators of Wnt-Signaling in Development and Cancer
van Noort, M., & Clevers, H. C. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0566 · Cited by 194
Axin is a scaffold protein in TGF‐β signaling that promotes degradation of Smad7 by Arkadia
Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M., Li, Q., Ye, Z., Chan, S. C., Chan, S. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601057 · Cited by 199
Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa, S., Itabashi, M., Adachi, S., Kawamoto, T., Hori, M., Shimazaki, J., Yoshimi, F., & Fukao, K. (2002) · PubMed · Cited by 193
The Canonical Wnt/β-Catenin Signalling Pathway
Barker, N. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-249-6_1 · Cited by 192
The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium
Teng, J., Rai, T., Tanaka, Y., Takei, Y., Nakata, T., Hirasawa, M., Kulkarni, A. B., & Hirokawa, N. (2005) · Nature Cell Biology · doi:10.1038/ncb1249 · Cited by 195
Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
Uematsu, K., Kanazawa, S., You, L., He, B., Xu, Z., Li, K., Peterlin, B. M., McCormick, F. P., & Jablons, D. M. (2003) · PubMed · Cited by 188
Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
Guo, Z. S., Thorne, S. H., & Bartlett, D. L. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.001 · Cited by 198
Activation of the Canonical Wingless/T-Cell Factor Signaling Pathway Promotes Invasive Differentiation of Human Trophoblast
Pollheimer, J., Loregger, T., Sonderegger, S., Saleh, L., Bauer, S., Bilban, M., Czerwenka, K. F., Husslein, P. W., & Knöfler, M. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050686 · Cited by 191
p38 mitogen-activated protein kinase regulates canonical Wnt–β-catenin signaling by inactivation of GSK3β
Bikkavilli, R. K., Feigin, M. E., & Malbon, C. C. (2008) · Journal of Cell Science · doi:10.1242/jcs.032854 · Cited by 193
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
Flahaut, M., Meier, R., Coulon, A., Nardou, K., Niggli, F. K., Martinet, D., Beckmann, J. S., Joseph, J.-M., Mühlethaler‐Mottet, A., & Gross, N. (2009) · Oncogene · doi:10.1038/onc.2009.80 · Cited by 193
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of β-catenin
Cong, F., & VARMUS, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307344101 · Cited by 189
Involvement of RNA Helicases p68 and p72 in Colon Cancer
Shin, S., Rossow, K. L., Grande, J. P., & Janknecht, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4652 · Cited by 190
Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro‐Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
Wnt and Bmp signalling cooperatively regulate gradedEmx2 expression in the dorsal telencephalon
Theil, T., Aydin, S., Koch, S., Grotewold, L., & Rüther, U. (2002) · Development · doi:10.1242/dev.129.13.3045 · Cited by 189
The ankyrin repeat protein Diversin recruits Casein kinase Iε to the β-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signalingPreprint
Schwarz-Romond, T., Asbrand, C., Bakkers, J., Kühl, M., Schaeffer, H.-J., Huelsken, J., Behrens, J., Hammerschmidt, M., & Birchmeier, W. (2002) · Genes & Development · doi:10.1101/gad.230402 · Cited by 192
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 192
Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 189
BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
Mani, M., Carrasco, D. E., Zhang, Y., Takada, K., Gatt, M. E., Dutta-Simmons, J., Ikeda, H., Diaz‐Griffero, F., Peña‐Cruz, V., Bertagnolli, M. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0773 · Cited by 191
The role of Rho GTPases in disease development
Boettner, B., & Van Aelst, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00426-2 · Cited by 229
Cell–cell connectivity: desmosomes and disease
Brooke, M. A., Nitoiu, D., & Kelsell, D. P. (2011) · The Journal of Pathology · doi:10.1002/path.3027 · Cited by 190
Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay
Osafune, K., Takasato, M., Kispert, A., Asashima, M., & Nishinakamura, R. (2005) · Development · doi:10.1242/dev.02174 · Cited by 189
ΔNp63 induces β-catenin nuclear accumulation and signaling
Patturajan, M., Nomoto, S., Sommer, M., Fomenkov, A. I., Hibi, K., Zangen, R., Poliak, N., Califano, J. A., Trink, B., Ratovitski, E. A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00057-0 · Cited by 187
Nr-CAM is a target gene of the β-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesisPreprint
Conacci‐Sorrell, M., Ben-Yedidia, T., Shtutman, M. S., Feinstein, E., Einat, P., & Ben‐Ze'ev, A. (2002) · Genes & Development · doi:10.1101/gad.227502 · Cited by 187
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Cao, Q., Lu, X., & Feng, Y. (2006) · Cell Research · doi:10.1038/sj.cr.7310078 · Cited by 186
Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis
Ysebaert, L., Chicanne, G., Demur, C., de Toni, F., Prade, N., Ruidavets, J.-B., Mas, V. M., Huguet, F., Laurent, G., Payrastre, B., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404239 · Cited by 192
Role of serine/threonine protein phosphatase 2A in cancer
Schönthal, A. H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00561-4 · Cited by 186
Acetylation of β-Catenin by CREB-binding Protein (CBP)
Wolf, D., Rodova, M., Miska, E. A., Calvet, J. P., & Kouzarides, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201196200 · Cited by 194
G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway
Yang, M., Zhong, W., Srivastava, N., Slavin, A., Yang, J., Hoey, T., & An, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501535102 · Cited by 188

Authors: Polakis, P.
Affiliations: Genentech (US)
Corresponding author: Polakis, Paul
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2000-08-01
Volume: 14
Issue: 15
Pages: 1837-1851
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.14.15.1837
OpenAlex: W2239090104
Cited by: 3,183
References: 190
Citations by year: 2026: 6 · 2025: 12 · 2024: 25 · 2023: 43 · 2022: 39 · 2021: 46 · 2020: 56 · 2019: 67 · 2018: 71 · 2017: 86 · 2016: 110 · 2015: 144 · 2014: 138 · 2013: 147 · 2012: 174
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
Keywords: Wnt signaling, β-catenin, cancer, oncogenic transformation, transcriptional activation, gene expression profiles, experimental tumor model
MeSH terms: Dishevelled Proteins, Animals, Cytoskeletal Proteins, Humans, Neoplasms, Phosphoprotein Phosphatases, Phosphoproteins, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Trans-Activators, Calcium-Calmodulin-Dependent Protein Kinases, Adenomatous Polyposis Coli Protein, Zebrafish Proteins, Glycogen Synthase Kinase 3, Adaptor Proteins, Signal Transducing, Wnt Proteins, beta Catenin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Wnt signaling and cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks